Synthesis and evaluation of 4-(2-hydroxypropyl)piperazin-1-yl) derivatives as Hsp90 inhibitors. 2016

Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

We previously reported 4-(3-((6-bromonaphthalen-2-yl)oxy)-2-hydroxypropyl)-N,N-dimethylpiperazine-1-sulfonamide (1) as a novel heat shock protein 90 inhibitor with moderate activity. In our ongoing efforts for the discovery of Hsp90 modulators we undertake structural investigations on 1. Series of the titled compound were designed, synthesized and evaluated. We have found that compounds with a hydroxyl group at C-4 of the aryl ring on the piperazine moiety possess Hsp90 inhibition properties. Compound 6f with improved activity could be further developed and optimized as Hsp90 inhibitor.

UI MeSH Term Description Entries

Related Publications

Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
February 2022, Journal of medicinal chemistry,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
November 2021, European journal of medicinal chemistry,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
April 2017, Archiv der Pharmazie,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
February 2017, Bioorganic & medicinal chemistry letters,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
January 2013, Bioorganic & medicinal chemistry letters,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
January 2017, Bioorganic & medicinal chemistry letters,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
December 2008, Bioorganic & medicinal chemistry letters,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
February 2023, Molecular diversity,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
July 2013, Archives of pharmacal research,
Bahidja Cherfaoui, and Tian-Kun Guo, and Hao-Peng Sun, and Wei-Lin Cheng, and Fang Liu, and Fen Jiang, and Xiao-Li Xu, and Qi-Dong You
March 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!